Johnston, Tom H <br/><br/>
A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates.  [electronic resource] 

 -  FASEB journal : official publication of the Federation of American Societies for Experimental Biology  May 2012 
 - 2154-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-6860 
<br/><br/><label>Standard No.: </label>10.1096/fj.11-195016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiparkinson Agents--therapeutic use<br/>Benzodioxoles--therapeutic use<br/>Cell Line, Tumor<br/>Drug Synergism<br/>Levodopa--therapeutic use<br/>Male<br/>Methylamines--therapeutic use<br/>N-Methyl-3,4-methylenedioxyamphetamine--analogs & derivatives<br/>Parkinson Disease--drug therapy<br/>Rats<br/>Rats, Sprague-Dawley